The Authority in Global Agricultural Chemistry & Bio-Resources

FDA updates GMP rules for botanical extract imports with stricter cGMP audits, registration, and quality checks. Learn who is affected, key deadlines, and how to protect clearance and market access.

REACH Adds 12 Botanical Extract Ingredients to SVHC List, raising new SCIP and SDS duties from October 2026. Learn how botanical extract exporters can manage compliance, avoid shipment delays, and protect trade continuity.

Botanical Extracts exporters face major change as the ECHA SVHC update adds new SCIP notification duties for EU trade. Learn the risks, deadlines, and compliance actions now.

ECHA Adds 27 SVHC Limits for Botanical Extracts under REACH Annex XVII. Learn key deadlines, compliance documents, and supplier screening impacts before October 1, 2026.

ECHA Tightens REACH Rules for Botanical Extract Exports: learn how new EU pre-registration and impurity report requirements affect customs clearance, supplier approval, and trade continuity.

FDA Tightens Import Proof for Botanical Extracts: learn how the new US rule on cGMP and ISO 22000 certification may affect clearance, supplier approval, and market access before October 2026.

EU REACH adds 17 botanical extract restrictions from August 2026. Learn how echinacea, curcumin, and green tea polyphenols rules may impact compliance, customs clearance, and EU market access.

FDA eases import path for 12 botanical extracts, cutting Prior Notice and sampling for USP-NF compliant batches. Learn how this update affects exporters, buyers, and GMP-driven market access.